ENDEFR
Home › Ireland › BRISTOL-MYERS SQUIBB PHARMACEUTICALS UNLIMITED COMPANY

BRISTOL-MYERS SQUIBB PHARMACEUTICALS UNLIMITED COMPANY

COMPANY · DUBLIN, Ireland · LEI 5493008GEQ35GOVSEM62
LEI lapsed

Summary

BRISTOL-MYERS SQUIBB PHARMACEUTICALS UNLIMITED COMPANY is registered in Ireland and entered in the “Companies Register (CRO)” under number 15797. According to GLEIF, its ultimate parent is BRISTOL-MYERS SQUIBB COMPANY (United States). That group has 26 subsidiaries with LEIs in 17 countries, 4 of them in Ireland. The LEI was first issued on 12 Mar 2013 and the record was last updated on 31 Jul 2023. It has lapsed: renewal was due by 27 Feb 2019. AssetCensus found 3 data-quality notes for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 27 Feb 2019 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
  • The ultimate-parent link rests on accounts for the period ending 31 Dec 2016, more than 24 months before this data release. The group may have changed since.
  • The ultimate-parent relationship record was not renewed; it was last updated on 31 Jul 2023.

Company details

Legal formCOMPANY
RegisterCompanies Register (CRO) · Register website
Registration number15797
Registration authorityCompanies Registration Office
JurisdictionIreland
Registered addressPLAZA 254, BLANCHARDSTOWN CORPORATE PARK 2 BALLYCOOLIN DUBLIN 15, D15 T867 DUBLIN, Ireland
Headquarters addressWATERY LANE, K67 AY91 SWORDS, Ireland
Categorycompany or other legal entity
Statusactive
LEI5493008GEQ35GOVSEM62
LEI statuslapsed
LEI first issued12 Mar 2013
LEI record last updated31 Jul 2023
Next LEI renewal27 Feb 2019
Corroboration of the LEI recordfully corroborated

Group membership

BRISTOL-MYERS SQUIBB COMPANY United States ultimate parent
BRISTOL-MYERS SQUIBB PHARMACEUTICALS UNLIMITED COMPANY this entity
View the whole group: 26 subsidiaries in 17 countries

Relationship to the parent

Ultimate parent
ParentBRISTOL-MYERS SQUIBB COMPANY
Accounting period1 Jan 2016 to 31 Dec 2016
Evidencesupporting documents
Corroborationpartly corroborated
Relationship start27 Feb 2018
Recorded at GLEIF since12 Mar 2013
Last updated31 Jul 2023
Record statusnot renewed

Parent not reported to GLEIF

  • Direct parent: the parent information is not public, because of legal constraints, possible detriment, or because consent was not obtained.

Other names

  • Bristol-myers Squibb Pharmaceuticals · previous name
  • Bristol - Myers Squibb Pharmaceuticals ULC · previous name